About: EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2001 (uk) im Juli 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2001 (ast) scientific article published on 01 July 2001 (en)
publication date	wds:Q74296810-38C7BD8C-B2F8-4D3C-8616-C85016C8A285
publication date	2001-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74296810-348CBB86-FFBB-4DA8-8F72-2C1E4C623BE0 wds:Q74296810-DA0A9197-3711-4267-B874-B547B5F94C27 wds:Q74296810-DF6247EF-EBBA-409C-B4BA-07AD7717E1BB
author name string	S M Huang G T Tucker J B Houston
rdfs:label	EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (en) EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (nl)
skos:prefLabel	EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (en) EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (nl)
name	EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (en) EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (nl)
title	wds:Q74296810-CE9A1C5F-0EBE-42BD-BBB4-A92CFD8B4EE4
title	EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences (en)
page(s)	wds:Q74296810-DED7773C-EEC3-43DE-AD70-AFEAC2734D04
page(s)	417-428
instance of	wds:Q74296810-A2450698-9CC4-4D19-8CD0-32779321B322
instance of	scholarly article
PubMed ID	wds:Q74296810-AB360D66-E630-4AFA-A625-6ADB97ECA67E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11480400
PubMed ID	11480400
published in	wds:Q74296810-61C40608-4826-428A-B137-05883A576DBD
published in	European Journal of Pharmaceutical Sciences
issue	wds:Q74296810-9A700D4B-CA41-47CE-8DDD-730FD1A078EA
volume	wds:Q74296810-C6B5C049-8D6A-4EC6-8771-AC9DEA1C4963
issue	4
volume	13
DOI	wds:Q74296810-26EFC629-9A75-4640-A5A2-67D3C4C0106F
DOI	http://dx.doi.org/10.1016/S0928-0987(01)00148-8
DOI	10.1016/S0928-0987(01)00148-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74296810
is cites work of	Membrane transporters in drug development The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development. In vitro tests for predicting drug-drug interactions: the need for validated procedures Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial. Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4. Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study Isolation, analysis and in vitro assessment of CYP3A4 inhibition by methylxanthines extracted from Pu-erh and Bancha tea leaves
is cites work of	wds:Q48759526-6320D6EF-4D3D-4DDD-BFC0-0B682CBB65BA wds:Q37365274-D4234C73-217D-4F26-BDBB-B5A75A4FEBF6 wds:Q46981888-72D0F60B-8BF7-457C-8BFF-433111BBF6B4 wds:Q44600279-4A7BBBFF-DCFD-41F5-865D-65E07AFFEB20 wds:Q35060620-1FCCB4B4-B093-4C86-B231-3E292CAEABFF wds:Q29616802-68D6D972-3D17-40AD-AD22-4FEEBC9D8989 wds:Q90317494-2EA6CC6B-2940-47FD-86DC-81C2F1CA13CE wds:Q40154652-4FC0E92B-7D1D-43FC-8B28-9F1707D19CA8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software